Recent News

• 09.08.2025 - MindMed Announces New Employee Inducement Grants
• 09.04.2025 - Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)
• 08.28.2025 - MindMed to Participate in September Investor Conferences
• 08.11.2025 - MindMed Announces New Employee Inducement Grants
• 07.31.2025 - MindMed Reports Q2 2025 Financial Results and Business Updates
• 07.24.2025 - MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025
• 07.14.2025 - MindMed Announces New Employee Inducement Grants

Recent Filings

• 09.04.2025 - EX-99.1 EX-99.1
• 09.04.2025 - 8-K Current report
• 07.31.2025 - EX-99.1 EX-99.1
• 07.31.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.31.2025 - 8-K Current report
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.25.2025 - 144 Report of proposed sale of securities
• 06.25.2025 - 144 Report of proposed sale of securities